gp120 Inhibitors (Praecis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namegp120 Inhibitors (Praecis)
Drug Alias NameCCR5 chemokine antagonist (Praecis)FLSC R/T IgG1
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionC-C chemokine receptor type 5 modulatorsHIV envelope protein gp120 modulators
TargetsHIV envelope protein gp120C-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPraecis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPraecis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A